|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 06821594.6 (espacenet) (Federated) (European Patent Register), 20061129 | Patent/reg. no. and date | DK/EP 1959939, 20120111 | Publication date | 20080827 | Priority no. and date | US 740631 P, 20051130 | EP pub. no. and date |
EP 1959939 20080827 | Effective date | | Applicant/owner | Can-Fite Biopharma Ltd., 10 Bareket Street P.O. Box 7537
Petach Tikva 49170, IL | Applicant ref. no. | 12036-5 | Inventor | FISHMAN, Pnina, 19 Asher Barash Street
46365 Herzliya, IL | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 31/00 (2006.01) , A61K 31/519 (2006.01) , A61K 31/7076 (2006.01) , A61P 19/02 (2006.01) | Title | ANVENDELSE AF A3-ADENOSINRECEPTORAGONIST I BEHANDLINGEN AF OSTEOARTHRITIS | Int. application no. | IL2006001374 | Int. publication no. | WO2007063538 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |